Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)
NCT00395473
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
141
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypercholesterolemia
Interventions
DRUG:
MK0653, ezetimibe / Duration of Treatment: 6 Weeks
Sponsor
Organon and Co